Preclinical assessment of Orteronel®, a CYP17A1 enzyme inhibitor in rats Mohd ZainuddinA. B. VinodRamesh Mullangi Original Paper 09 October 2014 Pages: 1 - 7
Correlation of elimination fraction area under the curve with total body clearance Tomasz GrabowskiAnna Raczyńska-PawelecJerzy Jan Jaroszewski Original Paper 14 October 2014 Pages: 9 - 18
Studies on pharmacokinetics and bioavailability of aminophylline in partridge chickens Bin YinJing LiRen-zhong Wan Original Paper 17 October 2014 Pages: 19 - 25
Metabolic pathway profiling of the derivative of important herbal component noscapine Yonghua YaoYang Xiong Original Paper 22 October 2014 Pages: 27 - 32
Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells Himanshu RastogiSnehasis Jana Original Paper 29 October 2014 Pages: 33 - 43
CYP3A4-based drug–drug interaction: CYP3A4 substrates’ pharmacokinetic properties and ketoconazole dose regimen effect Xavier BoulencOlivier NicolasCéline Ollier Original Paper 06 November 2014 Pages: 45 - 54
Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs John WiltonElena KurenovaGerald Fetterly Original Paper 07 November 2014 Pages: 55 - 67
In vitro metabolism of bencycloquidium bromide and its inhibitory effects on human P450 isoenzymes: implication of CYP2D6, CYP2C19 and CYP3A4/5 Janvier Engelbert AgbokpontoLingling ZhangLi Ding Original Paper 26 November 2014 Pages: 69 - 77
The role of CYP2C9 genetic polymorphism in carvedilol O-desmethylation in vitro Pei-Pei PanQing-Hua WengGuo-Xin Hu Original Paper 05 December 2014 Pages: 79 - 86
Tissue distribution and ontogeny of multidrug resistance protein 2, a phosphatidylcholine translocator, in rats Qiuyang ZhangWei YangXijing Chen Short Communication 05 October 2014 Pages: 87 - 91
